
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 08, 2025, titled "Strides Enters into a Strategic Product Development Partnership with Kenox to Expand Nasal Spray Portfolio for the US Market".
Filed with NSE ·

Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 08, 2025, titled "Strides Enters into a Strategic Product Development Partnership with Kenox to Expand Nasal Spray Portfolio for the US Market".
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science